Teyro

Chennai, India Founded: 2016 • Age: 10 yrs
Specializes in developing and manufacturing oncology pharmaceuticals.
Annual revenue $1.8M Latest available
Total funding - Funding intelligence
Employees 175 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Teyro

Teyro is a company based in Chennai (India) founded in 2016. It operates as a B2B. The company has 175 employees as of March 31, 2024. Teyro operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter Chennai, India
  • Employees 175 as on 31 Mar, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Teyro Labs Private Limited
  • Date of Incorporation 21 Feb, 2014
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.75 M (USD)
    498.07
    as on Mar 31, 2024
  • Net Profit
    -$2.7 M (USD)
    40.64
    as on Mar 31, 2024
  • EBITDA
    $3.51 M (USD)
    400.25
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    175

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Teyro

Premium access

Detailed funding history for Teyro

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Teyro

Investments
Premium access

Investment portfolio details for Teyro

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Teyro

Premium access

Detailed financials for Teyro

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Teyro Comparisons

Teyro Primary company
Description
Specializes in developing and manufacturing oncology pharmac...
Location
Chennai, India
Founded Year
2016
Annual Revenue
$1.75 M (USD)
Net Profit
-$2.7 M (USD)
EBITDA
$3.51 M (USD)
Employees
175
As of 2024
Premium access

Peer comparison for Teyro

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Teyro

Teyro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed competitors of Teyro

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Teyro

Premium access

Complete news archive for Teyro

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Teyro

Teyro was founded in 2016.

Teyro is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

As of Mar 31, 2024, the latest employee count at Teyro is 175.

Annual revenue of Teyro is $1.75M as on Mar 31, 2024.

Teyro operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, oncology, and drug development. Specializes in developing and manufacturing oncology pharmaceuticals. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.

Teyro's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available